Abstract:
An isolated plant cell having increased expression of one or more of a PXY and WOL nucleic acid molecule or polypeptide, a method of isolating a plant stem cell, a method of producing a plant-derived biologically active substance using the isolated plant stem cell are disclosed. The cells are undifferentiated, undergo self-renewal, proliferate, and have the ability to differentiate. Cultures of the plant cells minimize variation of cell growth and stably produce biologically active substances, even in long-term culture. Production of biologically active substances using the plant cells solves problems of dedifferentiated plant cell cultures, including decreased cell growth and decreased productivity during long term culture.
Abstract:
The present invention relates to animal feed additives and detection thereof in feed products. Additionally, the present invention relates to yeast cell wall components, their methods of isolation, and compositions and methods for the immunological detection thereof.
Abstract:
Methods of identifying infectious disease infection prior to presentation of symptoms, assays for identifying genomic markers of infectious disease, and methods for diagnosing the underlying etiology of infectious disease.
Abstract:
The present invention relates to DNA ligands capable of binding to aflatoxin and zearalenone. The invention relates also to methods for determining the presence and concentration of aflatoxin and zearalenone in samples such as agricultural and food products, and to methods for removing or reducing the level of aflatoxin and zearalenone in samples such as agricultural and food products. The invention further relates to methods for identifying DNA ligands capable of binding to aflatoxin and zearalenone. The invention further relates to new DNA sequences.
Abstract:
The present invention relates to a marker for diagnosis of fungal infections, which is sequentially activated in vivo in the presence of ß-1,3-glucan, which activates the Toll signaling pathway, to compositions for diagnosis of fungal infections in a specimen, and to a method for producing antibacterial substances. More particularly, the present invention has proved that a GNBP3-mediated ß-1,3-glucan recognition signal reaches pro-Spaetzle using three serine proteases as mediators, namely, modular serine protease (MSP), Spaetzle-processing enzyme activating enzyme (SAE), and Spaetzle-processing enzyme (SPE). Proteins involved with ß-1,3-glucan recognition signaling can be effectively used as compositions for detecting fungal infections in blood samples or the like.
Abstract:
Head smut is one of the most devastating diseases in maize, causing severe yield loss worldwide. The present invention describes the fine-mapping of a major QTL conferring resistance to head smut. Markers useful for breeding, and methods for conferring head smut resistance are described. Nucleic acid sequence from the genetic locus conferring head smut resistance is disclosed. Genes encoding proteins conferring head smut resistance are disclosed.
Abstract:
Expression systems that effect production of a GTPase activating protein in plants are used to modify plants to enhance their ability to resist trauma
Abstract:
Methods and devices for the detection of proteins secreted by the hyphal growth form of Candida species are disclosed. The disclosed devices may constitute a method for the diagnosis of acute or chronic infections, including candidiasis, caused by microorganisms of the species Candida, such as C. albicans, for example. The devices of the present invention incorporate antibodies specific to secreted aspartyl protease proteins whose expression is upregulated upon the conversion of the Candida species from the commensal to the pathogenic form. The antibodies may be used in assays to allow the diagnosis of candidal infections and disease conditions. Either monoclonal antibodies or polyclonal antibodies may be used, and in the case of the monoclonals, the specific epitopes of the SAP protein may be detected as well as the SAP protein itself.
Abstract:
Methods and reagents for screening for anti-microbial agents are provided. Diagnostic tools for assessing treatment of fungal infections are provided. Antimicrobial substances including substances useful for the treatment of fungal infections are provided. In some embodiments, the substances have antigen unmasking activity. In some embodiments the substances have fungicidal activity and surface antigen unmasking activity.